pSivida is engaged in developing tiny, sustained-release drug delivery products created to deliver drugs at a controlled or steady rate for months or years. The company is currently focused on treating chronic diseases of the back of the eye utilizing Durasert and BioSilicon, its core technology systems. pSivida’s headquarters are located in Watertown, Mass.  For more information, visit the company’s Web site at www.psivida.com.

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Each year the annual event provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. For more information on Biotechnology Industry Organization (BIO), visit www.bio.org.

Let us hear your thoughts below: